Filter
348
Filtered Results: 348
Text search:
Tanzania
Food
and
Drugs
Authority
Featured
Recommendations
43
New Publications
99
Language
Document type
No document type
222
Studies & Reports
69
Guidelines
35
Manuals
8
Strategic & Response Plan
8
Fact sheets
3
Training Material
1
Situation Updates
1
Infographics
1
Countries / Regions
Tanzania
40
Kenya
20
Uganda
15
Africa
14
Ethiopia
12
Global
12
Zambia
10
Rwanda
9
Malawi
9
Liberia
6
Sierra Leone
5
Nigeria
5
Congo, Democratic Republic of
5
Ghana
5
South Sudan
4
South Africa
4
West and Central Africa
4
India
3
Bangladesh
3
Namibia
3
Lesotho
3
East and Southern Africa
3
South–East Asia Region
3
Guinea
2
Zimbabwe
2
Eswatini/ Swaziland
2
Burundi
2
Latin America and the Carribbean
2
Senegal
1
Haiti
1
Somalia
1
Pakistan
1
Syria
1
Sudan
1
Botswana
1
Sri Lanka
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Southern Africa
1
Laos
1
Authors & Publishers
Publication Years
Category
Countries
118
Clinical Guidelines
37
Women & Child Health
25
Public Health
24
Key Resources
11
Capacity Building
9
Pharmacy & Technologies
5
Toolboxes
HIV
50
TB
24
AMR
19
Mental Health
17
Pharmacy
17
Refugee
12
COVID-19
10
NTDs
10
Disability
9
Rapid Response
7
Global Health Education
7
Caregiver
7
Ebola
6
Planetary Health
6
Conflict
5
Natural Hazards
4
Zika
3
Health Financing Toolbox
3
South Sudan
1
Specific Hazards
1
NCDs
1
Guidelines for the production of extemporaenous formulations and hospital based sterile preparations
In order to streamline and effectively control compounding of medicinal products in hospitals and pharmacies, these Guidelines for Production of Extemporaneous ... Hospital Based Sterile Preparations has been crafted. The purpose of these guidelines therefore is to assist pharmacists in discharging their legal and professional obligations to patients in the area of extemporaneous dispensing. This guidance will help to assure the safe and appropriate preparation and supply of extemporaneously prepared medicinal products to patients, where
the supply of such products is necessary.
Extemporaneous and hospital based sterile preparations are critical for patients whose clinical needs cannot be met by registered medicinal products. The guidelines outline the principles and application of the concepts of Good Manufacturing Practice (GMP) requirements for premises, equipment, personnel, storage, quality management system, quality control, compounding processes as well as documentation.
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
An Act to provide for the efficient and comprehensive regulation and control of food, drugs, med...
2014-2020, Draft March 2014
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
This fourth annual report monitors global progress towards the 2023 target for global elimination of industrially produced trans-fatty acids (TFA), highlighting achievements during the past year (October 2021 – September 2022). Countries are responding to the World Health Organization (WHO) call t...
Master of Science in Pharmaceutical Management Dissertation
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe in...
Review over the work and challenges of the Nigerian National Agency for Food and Drug Administration an... Control (NAFDAC) in combatting counterfeiting of medicines in Nigeria.
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tan...). These countries have been supported by WHO to strengthen their regulatory controls over antimalarial products. The survey was organized independently of manufacturers of antimalarial medicines.
Severe Acute Malnutrition (SAM) is one of the greatest child survival challenges in the world today and
reportedly affects more than 16.2 million children each year1. High impact, proven treatment interventions exist
yet sadly approximately only 3...
